Stonegate Capital Partners Initiates Coverage on Sirona Biochem Corp, Highlighting GlycoProteMim™ Potential
Stonegate Capital Partners initiates coverage on Sirona Biochem Corp, highlighting the potential of GlycoProteMim™ in the skincare market and the company's target of profitability by 2025.
This news matters as it sheds light on the growth potential of Sirona Biochem Corp and its GlycoProteMim™ product in the skincare industry, ultimately impacting the company's future profitability and market position.